Browsing by Subject "intravenous drug abuse"

Now showing items 1-5 of 5

    • Article  

      Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus 

      Demetriou, Victoria L.; Van De Vijver, D. A. M. C.; Hezka, Johana; Kostrikis, Leontios G.; Savvopoulou, Natasa; Georgiades, Neoklis; Charilaou, Charis C.; Argyriou, Argyris; Pavlou, Tina; Platritis, Kyriakos; Veresies, Kyriakos L. (2010)
      The most high-risk population for HCV transmission worldwide today are intravenous drug users. HCV genotypes in the general population in Cyprus demonstrate a polyphyletic infection and include subtypes associated with ...
    • Article  

      Hepatitis C virus infection epidemiology among people who inject drugs in europe: A systematic review of data for scaling up treatment and prevention 

      Wiessing, L.; Ferri, M.; Grady, B.; Kantzanou, M.; Sperle, I.; Cullen, K. J.; Hatzakis, Angelos E.; Prins, M.; Vickerman, P.; Lazarus, J. V.; Hope, V. D.; Matheï, C.; Busch, M.; Bollaerts, K.; Bogdanova, V.; Nesheva, E.; Fotsiou, N.; Kostrikis, Leontios G.; Mravčík, V.; Řehák, V.; Částková, J.; Hobstová, J.; Nechanská, B.; Fouchard, J.; Abel-Ollo, K.; Tefanova, V.; Tallo, T.; Brummer-Korvenkontio, H.; Brisacier, A. -C; Michot, I.; Jauffret-Roustide, M.; Zimmermann, R.; Fotiou, A.; Gazdag, G.; Tarján, A.; Galvin, B.; Thornton, L.; Cruciani, M.; Basso, M.; Karnite, A.; Caplinskiene, I.; Lopes, S.; Origer, A.; Melillo, J.; Camilleri, M.; Demanuele, C. O.; Croes, E.; Op De Coul, E.; Rosińska, M.; Struzik, M.; Martins, M.; Duran, D.; Vilar, G.; Resende, M. E.; Martins, H. C.; Abagiu, A. O.; Ruta, S.; Arama, V.; Kopilovic, B.; Kustec, T.; Klavs, I.; Aleixandre, N. L.; Folch, C.; Bravo, M. J.; Gómez, R. S.; Berglund, T.; Strandberg, J.; Hotho, D.; Van Houdt, S.; Low, A.; Mcdonald, B.; Platt, L.; Kalamara, E.; Giraudon, I.; Groshkova, T.; Palladino, C.; Hutchinson, S.; Ncube, F.; Eramova, I.; Goldberg, D.; Vicente, J.; Griffiths, P. (2014)
      Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention
    • Article  

      HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics 

      Abecasis, A. B.; Wensing, A. M. J.; Paraskevis, Dimitrios N.; Vercauteren, J.; Theys, K.; Van de Vijver, D. A. M. C.; Albert, Jan; Åsjö, Birgitta; Balotta, Claudia; Beshkov, Danail; Camacho, Ricardo J.; Clotet, B.; De Gascun, C.; Griskevicius, A.; Grossman, Z.; Hamouda, O.; Horban, A.; Kolupajeva, T.; Korn, K.; Kostrikis, Leontios G.; Kücherer, C.; Liitsola, K.; Linka, M.; Nielsen, C.; Otelea, D.; Paredes, R.; Poljak, M.; Puchhammer-Stöckl, E.; Schmit, J. -C; Sönnerborg, A.; Stanekova, D.; Stanojevic, M.; Struck, D.; Boucher, C. A. B.; Vandamme, A. -M (2013)
      Background: Understanding HIV-1 subtype distribution and epidemiology can assist preventive measures and clinical decisions. Sequence variation may affect antiviral drug resistance development, disease progression, ...
    • Article  

      An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I) 

      Gao, F.; Robertson, D. L.; Carruthers, C. D.; Li, Y.; Bailes, E.; Kostrikis, Leontios G.; Salminen, M. O.; Bibollet-Ruche, F.; Peeters, M.; Ho, David D.; Shaw, G. M.; Sharp, P. M.; Hahn, B. H. (1998)
      Full-length reference clones and sequences are currently available for eight human immunodeficiency virus type 1 (HIV-1) group M subtypes (A through H), but none have been reported for subtypes I and J, which have only ...
    • Article  

      Patterns of transmitted HIV drug resistance in Europe vary by risk group 

      Frentz, D.; Van De Vijver, D.; Abecasis, A. B.; Albert, Jan; Hamouda, O.; Jørgensen, L.; Kücherer, C.; Struck, D.; Schmit, J. -C; Vercauteren, J.; Åsjö, Birgitta; Balotta, Claudia; Bergin, C.; Beshkov, Danail; Camacho, Ricardo J.; Clotet, B.; Griskevicius, A.; Grossman, Z.; Horban, A.; Kolupajeva, T.; Korn, K.; Kostrikis, Leontios G.; Linka, K. L. M.; Nielsen, C.; Otelea, D.; Paraskevis, Dimitrios N.; Paredes, R.; Poljak, M.; Puchhammer-Stöckl, E.; Sönnerborg, A.; Stanekova, D.; Stanojevic, M.; Vandamme, A. -M; Boucher, C.; Wensing, A. (2014)
      Background: In Europe, a continuous programme (SPREAD) has been in place for ten years to study transmission of drug resistant HIV. We analysed time trends of transmitted drug resistance mutations (TDRM) in relation to the ...